In further research directions, co-cultivation of genetically modified patient-derived organoids with LEDGF/p75 knock-out and an overexpression of LEDGF/p75, from colorectal cancer patients with autologous immune cells might give insights into LEDGF/p75-dependent immune cell infiltration and therefore tackling the question of immune escape in cancer cells. This evidence concerns the gene PSIP1 and cancer.